PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.53
ESG score 90-95% of ANVS's 61.98. Bill Ackman would demand clear ESG improvement catalysts.
59.54
Environmental score exceeding 1.2x ANVS's 48.30. Mohnish Pabrai would examine if this environmental advantage creates sustainable cost advantages.
58.66
Social score 90-95% of ANVS's 62.81. Bill Ackman would demand clear social improvement catalysts.
57.40
Governance score below 80% of ANVS's 74.82. Jim Chanos would check for potential agency conflicts and oversight failures.